TB

Thomas P. Bobinski

MT Mirati Therapeutics: 8 patents #7 of 63Top 15%
AB Array Biopharma: 1 patents #256 of 335Top 80%
📍 San Diego, CA: #3,910 of 23,606 inventorsTop 20%
🗺 California: #55,401 of 386,348 inventorsTop 15%
Overall (All Time): #438,385 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
12371435 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2025-07-29
12037357 Compounds for activating invariant natural killer T-cells and methods of use in eliminating inflammatory senescent cells Matthew Duncton, Robin Mansukhani 2024-07-16
11912719 Substituted isoquinolines as rock kinase inhibitors Matthew Lee, Anthony Joseph Varano, Jr. 2024-02-27
11492351 MTA-cooperative PRMT5 inhibitors Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-11-08
11485738 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-11-01
11479551 MTA-cooperative PRMT5 inhibitors Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson +3 more 2022-10-25
11248004 Substituted isoquinolines as rock kinase inhibitors Matthew Lee, Anthony Joseph Varano, Jr. 2022-02-15
11220509 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2022-01-11
11091495 Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors Matthew Arnold Marx, Matthew Lee, Aaron Craig Burns, Nidhi Arora, James Gail Christensen +1 more 2021-08-17
10647715 KRas G12C inhibitors Matthew Arnold Marx, Aaron Craig Burns, John Gaudino, Julia Haas, John Michael Ketcham +5 more 2020-05-12
10266542 EZH2 inhibitors Matthew Arnold Marx, Matthew Lee, Robert A. Galemmo, Jr. 2019-04-23